PSA Thresholds for Prostate Cancer Detection

JAMA: The Journal of the American Medical Association

Volumn 278, Issue 9, 1997, Pages 699-700

  Parker, Mark E ^a  

^a Barberton Citizens Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

BLOOD; HUMAN; MALE; NEGRO; NOTE; PROSTATE TUMOR; ECONOMICS; MASS SCREENING; CANCER DIAGNOSIS; CANCER SCREENING; COST EFFECTIVENESS ANALYSIS; HIGH RISK POPULATION; LETTER; PREVALENCE; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATECTOMY; RACE DIFFERENCE;

AFRICAN CONTINENTAL ANCESTRY GROUP; HUMANS; MALE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; MASS SCREENING;

EID: 0030953423     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.1997.03550090023014     Document Type: Letter

References (1)

1. Catalona WJ, Smith DS, Ornstein DK. Prostate cancer detection in men with serum PSA concentrations of 2.6 to 4.0 ng/mL and benign prostate examination: enhancement of specificity with free PSA measurements. JAMA. 1997;277:1452-1455.